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Introduction
Urinary tract infections (UTIs) remain one of the
most common infections observed in community and
hospital based practice. They result in significant
morbidity and mortality while consuming large
amounts of national resources. It is estimated that 7
million episodes of cystitis occur annually in the
United States and the cost of caring for such
infections exceeds $1 billion [I]. Although most adult
(UTIs) are uncomplicated and respond rapidly to
antimicrobial therapy, they occasionally cause serious
and permanent renal damage. Due to the anatomical
continuity of the system infection may extend
throughout part or all of the urinary tract, and more
rarely, may involve the perinephric spaces[2]. The
incidence of (UTIs) in women is 10 times that in men
and amounts to an annual general practice consult-
ation rate of 62.5 per 1000 [3,4]. In institutionalised
elderly patients the prevalence of asymptomatic
bacteruria approaches 20-50% in women and 5-20%
in men [5]. Clearly on the basis of their prevalence
alone (UTIs) warrant careful consideration by
clinicians.
The emergence of the newer antibiotic classes,
including the second and third generation cephalos-
porins and the f1uoroquinolones, has provided the
clinician with agents that offer a broad spectrum of
activity, good patient acceptance, a well tolerated
safety profile, and convenient dosage regimens due to
their unique pharmacokinetic profiles [6].
Unfortunately (UTIs) remain a problem because of
the poor clinical application of the measures currently
available.
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Normal bladder urine is sterile. Kass in 1956 defined
significant bacteruria as the presence of 105 or more
colony forming units per millilitre of a midstream
sample of urine. Occasionally counts of 104 bacterial
ml should be taken into consideration as possible
(UTI), particularly in diabetic patients and those who
are immuno-compromised. Such counts may also be
relevant with complicated infections as a pure growth
of 104 of a given Gram negative organism cannot be
discounted. Contamination becomes more likely if
there is a mixed growth of bacteria. Where it is
possible to obtain uncontaminated samples, or in
symptomatic patients with low bacterial counts,
bladder bacteruria is diagnosed by the culture of urine
obtained by suprapubic aspiration. Pyuria is defined
as 10 or greater leucocytes per high-power field in
centrifuged urine [7]. It is supportive evidence of the
presence of a clinically important (UTI), but pus can
be present in "sterile" urine, where it may indicate a
fastidious organism such as mycobacteria or recent
treatment with antibiotics [4]. The leucocyte esterase
test on dipstick urinalysis is a rapid screen for the
presence of pyuria and a positive test correlates with
a minimum of 8-10 leucocytes per high-power field
[8]. Specimens need to be transported lo the
laboratory for culture without delay, and if stored for
'. a few hours should bekept at 4°C to prevent bacterial
proliferation artificially increasing the count. Pure
growths in lower counts may also indicate bladder
bacteruria in patients who are undergoing a water
diuresis by ingesting large amounts of fluid [91.
Recurrent attacks: Relapse or reinfection ?
Recurrent infection is a problem for both the clinician
and the patient. Relapsing infection is a recurrence of
bacteruria with the same organism within three weeks
of completing treatment which, during treatment,
rendered the urine sterile. It most often occurs in
association with renal scars, stones, cystic disease,
prostatitis, in patients with chronic interstitial
nephritis or in those who are irnmunocornpromised.
Patients who relapse should undergo detailed
investigation.
Reinfection is much more common than relapse and
accounts for 80% of recurrent infections. It is defined
as eradication of bacteruria by appropriate treatment,
followed by infection by a different organism after 7-
10 days. Unlike relapse, reinfection does not
represent failure to eradicate infection from the
uri nary tract, but is due to rei nvasion of the system.
Prophylactic measures must be initiated. Women with
recurrent (UTI) are more likely to be non-secretory of
blood group antigens [10]. A bio-chemical finger-
printing system has been designed for subtyping of
Eschereschia coli and is suitable for screening large
numbers of bacterial strains in patients with non-
obstructive pyelonephritis renal scarring and
recurrent (UTIs). This helps to determine whether
recurrent infections are relapses or reinfections lil].
Complicated vs uncomplicated (UTI)
Persistent or recurrent infection in adults with
anatomically and functionally normal urinary tracts
rarely lead to significant kidney damage.
Complicated infection is defined as infection
occuring in a structurally and functionally abnormal
urinary tract, or in a patient whose tract mayor may
not be normal but also has associated disease such
as diabetes, analgesic abuse or sickle cell trait.
Obstruction, stones or vesico-ureteric reflux
predispose to kidney damage, perinephric abscess,
septicaemia or a combination of the above. Such
compl icati ng factors also determi ne treatment
strategies [2].
Natural defence mechanisms of the urinary tract
These can be conveniently classified into non-
specific resistance mechanisms which protect against
microbial invasion in general, and specific immuno-
logically-based mechanisms which are directed
against particular micro-organisms [12]. The washout
effect of urine flow, vaginal normal flora, phago-
cytosis, bladder glycosaminoglycan and Tarnrn-
Horsfall glycoproteins all combine to have an
inhibiting effect against uropathogens. Specific
ilnmunological mechanisms include lower and upper
urinary tract secretory IgA supported by circulating
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IgM and IgG. In the experimental animal, T-cell
infiltration occurs in the kidney and transiently in the
bladder in ascending infection, and the prominence of
T-cell infiltrate correlates with the chronicity of renal
infection [13]. The persistence of renal infection has
been associated with enhanced suppressor T-cell
activity [14]. The outcome following the entrance of
micro-organisms into the urinary tract is a result of
competing forces which consist of local urinary
defence mechanisms, the initial numbers of micro-
organisms contaminating the urinary tract and
microbial virulence factors. (UTI) is facilitated by a
low urine flow rate and infrequent and incomplete
voiding.
In adults, women are 30 times more likely than men
to develop (UTI) [7]. Women who are sexually active
and especially if they use a diaphragm and
spermicide for contraception [I]. In one study
spermicide-coated condoms were responsible for
42% of the (UTIs) among women who were exposed
to these products [15]. The presumed mechanism is
colonisation of the vaginal and urethral mucosa with
intercourse facilitating migration of the organisms
into the bladder.
Diagnosis
Urine frequency, dysuria and suprapubic discomfort
are the characterisitc symptoms of cystitis. Pain and
burning may occur at the onset, during, or just after
urination. Physical examination is unremarkable in
most patients with lower (UTI). The diagnosis should
always be considered in patients with pyrexia of
uncertain origin. In uncomplicated pyelonephritis the
onset is commonly acute and mayor may not be
preceded by bladder symptoms. Many patients will
give a history of cystitis within the previous 6 months
[2]. Absence of bacteruria, despite symptoms of
frequency, urgency or dysuria, suggests acute urethral
syndrome or urethritis, or possibly vaginitis. Severe
renal infection may produce chills, rigors, high fever
and systemic symptoms of anorexia, nausea, vorniting
and generalised myalgia. Blood and urine cultures
have positive results and Gram-negative shock may
occur. Patients with diabetes mellitus, or those who
are immunosuppressed may have renal infection with
minimal local ising symptoms and signs. Renal
abscess is suggested by fever, rigors, loin pain and
tenderness with leucocytosis. Mid-stream urine may
be sterile but blood cultures are often positive. An
ultrasound scan will readily detect the perinephric
collection and also demonstrate a dilated renal pelvis
of a pyonephrosis. Diagnosis of prostatic infection is
most often made on the basis of symptoms such
as frequency, dysuria, perineal or groin pain, and the
finding of an enlarged tender prostate [2]. In the
absence of positive urine culture, prostatic massage
and repeat of culture may increase the yield.
9Micro-organisms
Dipstick tests can be used for rapid urine analysis.
Evidence of nitrate reduction to nitrite reflects the
presence of a Gram-negative organism, with the
exception of pseudomonas aeruginosa, which does
not often convert nitrate to nitrite [16]. Gram-positive
(UTIs) also do not convert nitrate to nitrite. Evidence
of leucocyte esterase in a urine specimen likewise
correlates with significant pyuria, reflecting a (UTI).
If either or both of dipstick tests are positive, urine
culture may be appropriate. However, if both are
negative, a more complete microscopic analysis and
culture can be avoided [16J.
Although (UTI) may occasionally be caused by
viruses and fungi, the overwhelming majority are
caused by bacteria. Most acute community-acquired
(UTI) in otherwise normal women is caused by
Gram-negative bacilli, usually by Eschereschia coli
derived from the bowel flora of the patient. Less
frequently other organisms are involved such as
Klebsiella, Enterobacter, Streptococci, and particu-
larly in young sexually active women Staphylococcus
saprophyticus [17J. There is evidence to suggest that
virulence is associated with the presence of
filamentous appendages (fimbriae or pili) on
uropathic strains of Eschereschia coli. These fimbriae
are of two main types that can be distinguished by
their haemagglutination properties. They attach to
receptors on the uroepithelium, urinary mucus and
Tamm-Horsfall glycoprotein. The genes of fimbriae
are located on the bacterial chromosome [12J.
Adherence of bacteria to uroepithelial cells is a
prerequisite for colonisation, persistence and
infection, particularly in a system' of continuous
urinary flow including the powerful effect of
micturition.
Eschereschia coli strains isolated from (UTI) belong
to a restricted range of O-serotypes particularly 0 I,
02, 04, 06, 07 and 075. These O-serotypes are also
found in the faeces of patients and can frequently be
isolated from their faeces before the onset of (UTl)
[18J. The endotoxin activity of lipopolysccharide
induces shedding of bladder epithelial cells [19],
reduces ureteric peristalsis and may contribute to
renal parenchymal damage by granulocyte activation.
As with O-antigens a limited number of K-antigens is
found on E.coli strains associated with (UTI) [20] but
there appears to be no difference in the frequency
with which these are found in upper and lower (UTI).
E. coli produces o.-haernolysin, which is secreted and
present in culture supernatants, and ~-haemolysin,
which is cell-associated [2]. The association between
haemolysin production and virulence is now well
established. Figure I shows the frequency of different
community acquired (UTI) pathogens in the authors'
hospital in 1997.





Radiological investigations of (UTIs)
The extent to which an individual patient should be
investigated varies tremendously. A plain abdominal
film is valuable in assessing the size of the kidneys,
localising mal-positioned kidneys, and in detecting
calculi or renal calcification. Intravenous urography
(lVU) has been an important diagnostic tool in
selected patients (Table 1). Ultrasonography is useful
in the detection and percutaneous drainage of
E. coli
67%
hydronephrosis, particularly when an intravenous
urogram is not possible due to renal functional
impairment.
The investigation of vesico-ureteric reflux requires a
voiding cysturethrograrn [21 J or an indirect
radionuclide cystogram which has the advantages of
reduced radiation dosage' and avoiding bladder
catheterisation. Dimercaptosuccinic acid (DMSA)
scan is helpful in detecting ectopic kidneys and
cortical scars.
Table 1. Indications for an IVU
All males.
Recurrent infections in women.
• Persistent haernaruria.
• Failure to respond to treatment.
• History of childhood UTls.
• Persisting sterile pyuria.
Anti-microbial agents: dose and duration
The effect of an anti-microbial on the faecal and
vaginal flora is an important property that influences
long term care. Treatment choices include single
dose, 3-day, 7-day and two weeks regimens. The
single dose has lost favour because of increased
recurrence and fewer cure rates [7]. Amoxycillin
resistance is rising and therefore it is no longer the
first line antibiotic of choice. Resistance to trime-
thoprim alone or in combination with sulpharnetho-
xazole is 5-15% whi Ie resistance to fluoroquinolones
is less than 5% [22]. Trimethoprim and trirnethoprim-
sulphamethoxazole are the optimal choices for
empirical 3 days therapy of uncomplicated (UTI) as
the fluoroquinolones are more expensive. The oral
cephalosporins are excreted in active form in high
concentration in the urine but have no special
advantage as first line drugs. Post-treatment cultures
are not routinely indicated.
Patients with mild acute pyelonephritis may be
treated in the community especially in the absence of
nausea and vomiting. Trimethoprim-sulpharnetho-
xazole or ciprotloxacin may be given for 10-14 days.
Patients with moderate or severe illness require
hospitalisation and treatment with parenteral anti-
biotics such as ceftriaxone or ciprofloxacin until the
fever is gone and then oral antibiotics for 14 days
[22]. Urological consultation and evaluation of the
upper urinary tract should be considered if the patient
remains febrile after 72 hours of treatment to rule out
the presence of nephrolithiasis, renal or perirenal
abscesses or other complications of pyelonephritis.
All patients require a post treatment culture after two
weeks of treatment [23].
Patients with acute bacterial prostatitis presenting
with voiding difficulty require hospital admission.
Treatment should be continued for 4-6 weeks and
urethral catheterisation should be avoided. Supra-
pubic drainage may be used to treat retention.
Asymptomatic bacteruria
The diagnosis implies absence of symptoms and
PYUria in urine analysis. Urine culture must demo-
nstrate bacterial growth of greater than 105 colony
forming units/ml from two separate clean-catch
midstream specimens. Patients who may benefit from
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antibiotic treatment are those with clean intermittent
catheterisation, those with abnormal urinary tracts
such as congenital polycystic kidneys and medullary
sponge kidney, those with acquired abnormalities
such as obstruction and renal calculi, and those
planning to have urinary tract instrumentation.
Antibiotic therapy is also appropriate for patients
with diabetes mellitus, mechanical prosthesis,
immuno-suppression, renal transplants and pre-
existing renal dysfunction. Treatment protocols
suggest single-dose therapy such as trimethoprim-
sulphamethoxazole if the organism is susceptible. A
repeat culture should be done at two weeks post-
treatment [7].
Infection in pregnancy
Asymptomatic bacteruria occurs in up to 7% of
pregnant women, and of those, about 30% develop
acute pyelonephritis if not treated [24]. Diminished
ureteral peristalsis and a change in urinary pH
contribute to the increased risk. Amoxycillin is
effective in up to two third of cases; other choices
include cephalexin, nitrofurantoin, and sulpho-
namides (except in the third trimester). Seven day
course appears to have better cure rates than shorter
courses of therapy [25]. A urine culture one week
later is advised to document cure, and repeated every
4 to 6 weeks unti I deli very [24].
Catheter-related infections
Indwelling bladder catheters are implicated in 40-
75% of all hospital-acquired (UTI). Even with the
best methods of aseptic closed drainage, colonisation
of bladder urine will occur in half the patients within
10 days to 2 weeks. For catheters in place for up to
14 days, the use of prophylactic antibiotics within 48
hours prior to catheter removal reduces the risk of
bacteruria fivefold [26]. In longterm catheterised
patients, systemic antibiotics should be used only
when signs and symptoms strongly suggest a urinary
tract origin. Treatment is directed to more resistant
organisms, especially in hospital acquired infections.
Infections complicated by bacteraemia should be
treated for 10-14 days, but if no bacteraernia is
present, a shorter course (3 to 5 days) usually clears
the bacteraernia and does not select out more resistant
organisms [27].
Candidal infection
The presence of yeast in the urine is most often due
to colonisation of the bladder by Candida albicans or
other Candida species. Positive urine cultures may be
the first sign of systemic candida I infection. Risk
factors for the development of candiduria include the
use of broad spectrum antibiotics, corticosteroids and
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indwelling bladder catheters, diabetes mellitus,
urological abnormalities and haematological malign-
ancies [28]. Discontinuing any unnecessary steroid or
antibiotic therapy may be helpful. Amphotericin
bladder irrigation for 5 days (50 mg/l sterile water
every 24 hours) has been used successfully [27].
Alternative treatments include oral fluconazole 50-
100 mg daily for 7 days or a single dose of
intravenous amphotericin B [28].
Prophylaxis
Continuous low dose suppression is effective at
reducing the recurrent rates for (UTI) by 95% among
sexually active women. Trimethoprim (I OOmg),
trimethoprim-sulphamethoxazole (960mg), and nitro-
furantoin (50-1 OOmg) have all been shown to be very
effective [29]. These drugs have to be given last thing
at night as a high fluid intake and frequent voiding
could maintain bacterial clearance by day. Side
effects and the emergence of resistant strains are
unusual. Most authorities recommend a 6 month to 2
year trial of prophylaxis, but as long as 5 years has
been reported to be effective and well tolerated [30]
(Table 2).
Table 2. Indications for prophylaxis
• Women with recurrent infections.
After acute pyelonephritis in pregnancy.
Pregnancy with history of childhood infections.
Persistent or relapsing infections in patients with
renal stones, scars or prostatitis.
•
References
I. Hooton TM, Scholes D and Hughes J el al: A prospective
study of risk factors for symptomatic urinary tract infection in
young women. N Engl J Med 1996; 335: 468-474.. .
2. Cattell WR: Lower and upper urinary tract infection In the
adult. Oxford Textbook of Clinical Nephrology. Oxford
Medical Publications, 1997; 1241-1259. .
3. Sweny P, Farrington K and Moorhead JF: Urinary tract
infections. The Kidney and its disorders. Blackwell, 1989;
621-650. .
4. Wilkie ME, Almond MK and Marsh FP: Diagnosis and
manag-ement of urinary tract infections in adults. Br Med J
1992; 305: 1137-1141.
5. Schaffer AJ: Urinary tract infections in the elderly. Eur Urol
1991; 19 [Suppl I]: 2-6 .
6. Faro S: New considerations in the treatment of urinary tract
infections in adults. Urology 1992; 39 (I): I-II.
7. Bacheller CD and Bernstein JM: Urinary tract infections. Med
Clin North Am 1997; 81(3),719-730.
8. Kusumi RK Grover PG and Kunin CM: Rapid detection of
pyuria by le~cocyte esteraseactivity. JAMA 1981; 245: 1653.
9. Cattell WR: Urinary tract infection in adults. Postgraduate
Med J 1985; 61: 907-913. .
10. Sheinfeld 1, Schaeffer AJ and Cordon-Cardo C el al: Associ-
ation of the Lewis blood group phenotype with recurrent
urinary tract infections. N Engl J Med 1989; 320: 773.
II. Jacobson SH. Kuhn I and Brauner A: Biochemical finger-
printing of urinary Escherechia coli causing recurrent
infections in women with pyelonephritic renal scarring. Scand
JUral Nephrol 1992; 26 (4): 373-377.
12. Sussman M: Microbiology and defences of the urinary tract.
Oxford textbook of clinical nephrology. Oxford medical
publications 1992; 1659-1676.
13. Hjelm EM: Local cellular immune response in ascending
urinary tract infection: Occurrence of T-cells, immunoglobulin
producing cells, and IgA expressing cells in rat urinary tract
tissue. Infect Immun 1984: 44: 627.
14. Miller TE, Marshal E and Nelson 1: Infection induced
immuno-suppression in pyelonephritis: Characteristics of the
suppressor cells. Kidney Int 1983: 24: 313.
15. Russo T, Brown JJ, Jodush ST and Johnson JR: The 04
specific antigen moiety of lipopolysccharide but not the K54
group 2 capsule is important for urovirulence of an
extraintestinal isolate or Eschereschia coli. Infect lrnmun
1996.64(6): 2343-2348
16. Wisinger DB: Urinary tract infection: current management
strategies. Postgrad Med 1996; 100 (5): 229-236.
17. Paed L, Maskell R, Morris J: Staphylococcus saprophyticus as
a urinary pathogen: a 6 year prospective survey. Br Med J
1985; 291: 1157-1159.
18. Lidin-Janson G: Comparison of Eschereschia coli from
bacteruric patients with those from faeces of healthy school-
children. J Infect Dis 1977; 136: 346-353.
19. Aronson M, Mcdalia 0 and Amichay D el al : Endotoxin-
induced shedding of viable uroepithelial cells is an anti-
microbial defence mechanism. Infect lmrnun 1988; 56: 1615-
1617.
20. Kajiser B, Larsson P and Oiling S el al : protection against
acute pyelonephritis caused by Eschereschia coli in rats using
isolated antigen conjugated to bovine serurn albumin. Infect
Immun 1983;31: 142-146.
21. Arant BS: Vesicoureteric reflux and renal injury. Am J Kid
Dis 1991; 17: 491-5 I I.
22. Stamm WE. Hooton TM: Management of urinary tract
infection in adults. N Engl J Med 1993; 329: 1328.
23. Hooton TM, Stamm WE: Management of acute uncomp-
licated urinary tract infection in adults. Mcd Clin North Am
1991; 75: 339-357.
24. Blint AJ and Hill D: Bactcruria of pregnancy-an update on
significance, diagnosis and management. J Antimierob
Chemo-thor 1991; 33 [suppl A I: 93-97.
25. Andriole VT and Patterson TF: Epidemiology. natural history
and management of urinary tract infections in pregnancy. Med
Clin North Am 1991: 75: 359-373.
26. Hustinx WNM, Mintjes de Groot AJ, Verkoycen RP and
Verbrugh HA: Impact of concurrent antimicrobial therapy on
catheter-associated urinary tract infection . .I Hasp Infect 1991;
18: 45-56.
27. Warren JW: Catheter-associated urinary tract infections. Infect
Dis Clin North Am 1987; I: 823-854.
28. Jacobs LG; Fungal urinary tract infections in the elderly:
treatment guidelines. Drugs and Aging 1996: 8 (2): 89-96.
29. Rubin RH, Tolkoff-Rubin NE and Cotran RS: Urinary tract
infection, pyelonephritis and reflux nephropathy. The Kidney
vol II. Philadelphia: WB Saunders 1991; 1369-1429.
30. Nicolle LE, Harding GKM and Thompson M el al: Efficacy of
5 years of continuous low dose rrimethoprim-sulpharnetho-
xazolc prophylaxis for urinary tract infection. J Infect Dis
1988; 157: 1239.
Acknowledgement
This work is supported by the Alan Squirrell renal
research fund.
